FIELD: medicine, pharmaceutics.
SUBSTANCE: given invention refers to new 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole derivatives, which can be used for modulating histamine receptors in individuals or for treating neurodegenerative diseases. The above derivatives have formula , wherein R1 is specified in an alkyl, substituted alkoxy or phenyl, and aralalkyl; R2 is specified in an alkyl, C6-C14-aryl optionally substituted by 1 to 5 substitutes specified in alkoxy and alkyl; R3 is an alkyl; and R4 is an alkyl.
EFFECT: presented are the new compounds effective as histamine receptor modulators, and a based pharmaceutical composition.
20 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
NEW APPROACH TO TREATMENT OF ALZHEIMER'S DISEASE | 1995 |
|
RU2106864C1 |
DERIVATIVES OF HYDROGENATED PYRIDO[4,3-B]INDOLES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT | 1995 |
|
RU2140417C1 |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508096C2 |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING ATYPICAL NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508106C2 |
PYRAZOLEPYRIMIDINONES FOR TREATMENT OF IMPOTENTS | 1994 |
|
RU2130776C1 |
LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND USE THEREOF | 2008 |
|
RU2407744C2 |
DERIVATIVES OF AZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF ELICITING ACTIVITY WITH RESPECT TO SEROTONIN 5-HT- | 1995 |
|
RU2146256C1 |
CORTICOTROPIN-RELEASING FACTOR ANTAGONISTS | 1995 |
|
RU2221799C2 |
REMEDY FOR IMPROVEMENT OF COGNITIVE FUNCTIONS AND MEMORY BASED ON HYDRATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL REMEDY BASED THEREON AND METHOD OF APPLICATION THEREOF | 2006 |
|
RU2334514C1 |
N,N'-SUBSTITUTED 3,7-DIAZABICYCLO[3,3,1]NONANES WITH PHARMACOLOGICAL EFFECT, PHARMACOLOGICAL COMPOSITIONS ON THEIR BASE, AND APPLICATION METHOD | 2006 |
|
RU2333211C1 |
Authors
Dates
2015-03-20—Published
2008-01-25—Filed